Meyka AI API is live for developers.Start building.
Advertisement
BrainsWay Ltd.

BrainsWay Ltd. (BWAY) Stock Overview

Explore BrainsWay Ltd.’s financial performance, market position, analyst ratings, and future outlook.

BWAYNASDAQ
HealthcareMedical - Devices
$13.89
$0.38(2.66%)
U.S. Market opens in 53h 25m
Advertisement

BrainsWay Ltd. (BWAY)

Meyka AI Score

Z

Key Financials

Market Cap544.8M
P/E Ratio29.95
EPS (TTM)$0.22
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$23.28
3 Months$26.73
1 Year Target$28.87

BWAY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BrainsWay Ltd. (BWAY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.30, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $28.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 29.95 and a market capitalization of 544.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.66%
5-Day Change
-12.81%
1-Month Change
-15.41%
3-Month Change
10.06%
6-Month Change
60.76%
Year-to-Date (YTD) Change
46.06%
1-Year Change
169.19%
3-Year Change
1339.38%
5-Year Change
141.57%
All-Time (Max) Change
150.27%

Contact Information

972 2 582 4030
Bynet Building, Jerusalem, NaN, 9777518

Company Facts

120 Employees
IPO DateApr 17, 2019
CountryIL
Actively Trading

Frequently Asked Questions